White Diamond Research | TalkMarkets | Page 1
Contributor's Links: White Diamond Research
White Diamond Research looks for special situations and stocks with the potential for big moves in the near future up or down. We specialize in the technology, energy and health care sectors, since those have the most interesting, misunderstood companies. However, we research special situations in ...more

Articles

Latest Posts
1 to 5 of 5 Posts
Why Cocrystal Pharma Will Fade Today’s Rally
COCP was trading lower than their $1.30 offering price last Friday and at $0.50 the day before they announced working on a coronavirus vaccine.
New Age Beverages Is About To Take A Spill After Parabolic Rise With Many Upcoming Negative Catalysts
The Company’s recent ‘key’ licensing deal to sell Marley branded CBD drinks comes with unfavorable economics as NBEV will pay a high 50% of gross margin for the license.
Delcath Systems Share Price Has Risen Over 1000% In The Past Month On No News And Is Engaged In Death Spiral Financing
Delcath is engaging in death spiral financing, and the convertible note holders can buy shares at a 15% discount to the recent market price and immediately sell. It's clinical trials are on the same technology that the FDA failed to approve in 2013.
PDL BioPharma Is A Solid Biotech Investment In A Friendly Regulatory Environment
Despite reaching a low in its downtrend, PDL expects to remain profitable, has a large cash position, and a share buyback is in place.
If Ominto Was A Private Company It Would Be Worth A Fraction Of Its Current Price
For the past four years, Ominot has had miniscule to no growth, only about $20 million per year in revenues, and loses about $10 million per year. We estimate Ominto’s value to be $1-$2 per share, for an eventual 90% decline.
1 to 5 of 5 Posts